Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 22% ± 7% | |
| endothelial cell of artery | 5 studies | 31% ± 6% | |
| hematopoietic stem cell | 4 studies | 47% ± 16% | |
| hematopoietic precursor cell | 3 studies | 44% ± 13% | |
| epithelial cell of proximal tubule | 3 studies | 27% ± 7% | |
| retinal ganglion cell | 3 studies | 36% ± 13% | |
| capillary endothelial cell | 3 studies | 24% ± 7% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 48% ± 15% | |
| parietal epithelial cell | 3 studies | 30% ± 9% |
Insufficient scRNA-seq data for expression of NPR3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 4787.08 | 89 / 89 | 88% | 63.53 | 794 / 901 |
| lung | 100% | 2947.56 | 576 / 578 | 64% | 8.64 | 735 / 1155 |
| prostate | 87% | 1044.62 | 213 / 245 | 74% | 19.31 | 370 / 502 |
| thymus | 98% | 2068.49 | 643 / 653 | 49% | 7.41 | 298 / 605 |
| adrenal gland | 87% | 883.50 | 225 / 258 | 38% | 6.31 | 88 / 230 |
| uterus | 81% | 758.28 | 138 / 170 | 32% | 3.09 | 145 / 459 |
| breast | 62% | 1075.37 | 285 / 459 | 42% | 5.38 | 468 / 1118 |
| skin | 97% | 1917.92 | 1749 / 1809 | 5% | 0.89 | 23 / 472 |
| blood vessel | 98% | 2502.20 | 1312 / 1335 | 0% | 0 | 0 / 0 |
| liver | 67% | 489.75 | 152 / 226 | 24% | 2.22 | 99 / 406 |
| adipose | 90% | 2499.92 | 1088 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 55% | 408.82 | 99 / 180 | 35% | 3.63 | 149 / 430 |
| heart | 89% | 2065.05 | 767 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 48% | 522.55 | 692 / 1445 | 40% | 5.98 | 74 / 183 |
| intestine | 71% | 1122.45 | 689 / 966 | 12% | 1.38 | 65 / 527 |
| spleen | 83% | 1297.06 | 200 / 241 | 0% | 0 | 0 / 0 |
| bladder | 62% | 443.81 | 13 / 21 | 13% | 1.35 | 66 / 504 |
| pancreas | 2% | 12.23 | 8 / 328 | 67% | 8.75 | 120 / 178 |
| muscle | 52% | 911.57 | 419 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 36% | 4.26 | 16 / 45 |
| stomach | 24% | 140.47 | 87 / 359 | 8% | 0.43 | 22 / 286 |
| brain | 2% | 9.62 | 61 / 2642 | 6% | 0.69 | 39 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001525 | Biological process | angiogenesis |
| GO_0001974 | Biological process | blood vessel remodeling |
| GO_0002931 | Biological process | response to ischemia |
| GO_0007165 | Biological process | signal transduction |
| GO_0008217 | Biological process | regulation of blood pressure |
| GO_0033688 | Biological process | regulation of osteoblast proliferation |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0002158 | Biological process | osteoclast proliferation |
| GO_0001501 | Biological process | skeletal system development |
| GO_0051000 | Biological process | positive regulation of nitric-oxide synthase activity |
| GO_0035810 | Biological process | positive regulation of urine volume |
| GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0031404 | Molecular function | chloride ion binding |
| GO_0042277 | Molecular function | peptide binding |
| GO_0042562 | Molecular function | hormone binding |
| GO_0017046 | Molecular function | peptide hormone binding |
| GO_0008528 | Molecular function | G protein-coupled peptide receptor activity |
| GO_0016941 | Molecular function | natriuretic peptide receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NPR3 |
| Protein name | Natriuretic peptide receptor C Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C) Natriuretic peptide receptor 3 |
| Synonyms | C5orf23 hCG_37223 NPRC ANPRC |
| Description | FUNCTION: Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance receptor for NPPA, NPPB and NPPC, regulating their local concentrations and effects. May regulate diuresis, blood pressure and skeletal development. Does not have guanylate cyclase activity. . |
| Accessions | ENST00000265074.13 [P17342-1] ENST00000434067.6 C9JK69 H0Y9B9 P17342 ENST00000509104.5 D6RDL8 ENST00000507141.1 Q60I31 ENST00000326958.5 [P17342-3] ENST00000415167.2 [P17342-2] |